Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Linzess for the Treatment of Irritable Bowel Syndrome with Chronic Idiopathic Constipation

Drug (Brand / Generic)

Linzess / linaclotide

Developed by

Forest Laboratories, Ironwood Pharmaceuticals

Therapy Class

Guanylate cyclase-C (GC-C) agonist

Current Indications

Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation (CIC)

Market Sector

Gastroenterology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top